These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30305803)
21. Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy. Chen LC; Li SH; Lo CM; Chen YH; Huang SC; Wang YM; Chou SY; Lu HI J Thorac Dis; 2019 Nov; 11(11):4583-4590. PubMed ID: 31903247 [TBL] [Abstract][Full Text] [Related]
22. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma. Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589 [No Abstract] [Full Text] [Related]
23. Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma. Yang Y; Tan H; Lu Y; Mei J; Zhang M; Bai M; Wang X; Ge S; Ning T; Zhang L; Ji Z; Duan J; Sun Y; Wang F; Liu R; Li H; Deng T BMC Cancer; 2024 Feb; 24(1):249. PubMed ID: 38389042 [TBL] [Abstract][Full Text] [Related]
24. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. Zhao Q; Chen S; Feng JF Oncotarget; 2017 Nov; 8(61):103535-103542. PubMed ID: 29262582 [TBL] [Abstract][Full Text] [Related]
26. Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas. Chen C; Chen G; Wu Y; Li J Transl Cancer Res; 2020 May; 9(5):3483-3490. PubMed ID: 35117713 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479 [TBL] [Abstract][Full Text] [Related]
28. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. Liu JS; Huang Y; Yang X; Feng JF Am J Cancer Res; 2015; 5(7):2180-9. PubMed ID: 26328248 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Xie X; Luo KJ; Hu Y; Wang JY; Chen J Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116 [TBL] [Abstract][Full Text] [Related]
30. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio. Lv Y; Zhang J; Liu Z; Tian Y; Liu F Medicine (Baltimore); 2019 Feb; 98(7):e14562. PubMed ID: 30762804 [TBL] [Abstract][Full Text] [Related]
31. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma. Zhao K; Wang C; Shi F; Li M; Yu J Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751 [TBL] [Abstract][Full Text] [Related]
32. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689 [TBL] [Abstract][Full Text] [Related]
33. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428 [TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma. Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma. Song S; Chen H; Dong W; Zhou H Acta Otolaryngol; 2019 Mar; 139(3):294-298. PubMed ID: 30882257 [TBL] [Abstract][Full Text] [Related]
37. Pretreatment BAN Score Based on Body-mass-index, Albumin and Neutrophil-lymphocyte Ratio Could Predict Long-term Survival for Patients with Operable Esophageal Squamous Cell Carcinoma. Zhang F; Bu LJ; Wang R; Da J; Ding JX; Peng WR J Cancer; 2022; 13(9):2768-2774. PubMed ID: 35812183 [No Abstract] [Full Text] [Related]
38. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy. Zhang H; Guo XW; Yin XX; Liu YC; Ji SJ Cancer Manag Res; 2019; 11():9459-9468. PubMed ID: 31819611 [TBL] [Abstract][Full Text] [Related]
39. The prognostic role of a combined fibrinogen and inflammation-based index in patients with metastatic breast cancer. Liu Q; Fang S; Liang S; Lv J; Wang G; Tang R; Ji X; Zhao T; Li J; Xu L; Ma L; Wang R; Li H Transl Cancer Res; 2020 Nov; 9(11):7065-7078. PubMed ID: 35117312 [TBL] [Abstract][Full Text] [Related]
40. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]